Cargando…
Risk factors for colistin-resistant Enterobacteriaceae in a low-endemicity setting for carbapenem resistance – a matched case–control study
Emergence of colistin resistance has been related to increased use in clinical settings, following global spread of carbapenem-resistant Gram-negative bacteria. Use of colistin in animal production may constitute a further source of spread of resistant strains to humans. We sought to determine risk...
Autores principales: | Büchler, Andrea C, Gehringer, Christian, Widmer, Andreas F, Egli, Adrian, Tschudin-Sutter, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153431/ https://www.ncbi.nlm.nih.gov/pubmed/30064544 http://dx.doi.org/10.2807/1560-7917.ES.2018.23.30.1700777 |
Ejemplares similares
-
2446. Clinical Spectrum and Outcomes of Colistin-Resistant Carbapenem-Resistant Enterobacteriaceae
por: Ahmed, Sara, et al.
Publicado: (2018) -
Increasing trends of colistin resistance in patients at high-risk of carbapenem-resistant Enterobacteriaceae
por: El-Mahallawy, Hadir A., et al.
Publicado: (2022) -
2186. High Adherence to Contact Precautions of Patients with Multidrug-resistant Organisms (MDRO) and Low In-Hospital Transmission of MDROs
por: Büchler, Andrea C, et al.
Publicado: (2018) -
Colistin-resistance gene mcr in clinical carbapenem-resistant Enterobacteriaceae strains in China, 2014–2019
por: Huang, Hong, et al.
Publicado: (2020) -
Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran
por: Goudarzi, Zahra, et al.
Publicado: (2023)